Paul Nouri, CFP
Hedge fund manager, long/short equity, healthcare

Deep Value In This Diagnostic Company Might Attract Activists

Despite 2013 being one of the best years for IPO's in recent memory, shares of Liposcience (NASDAQ:LPDX), which went public at $9, quickly rose to $11 only to plummet to $4 by the end of the year.

The company faced challenges on many different fronts in 2013. After a profitable 2012, the company lost $12.5 million in 201...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.